Skip to content

Clinical trials

Completed Multiple Sclerosis trials in Estonia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Estonia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20073
20086
20092
20101
20112
20131
20142
20151
20162
20182
20192
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Sanofi4
Biogen3
Merck KGaA, Darmstadt, Germany3
Teva Branded Pharmaceutical Products R&D, Inc.3
Celgene2
EMD Serono Research & Development Institute, Inc.2
GeNeuro SA1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis28
Multiple Sclerosis, Relapsing-Remitting7
Recurrence6
Multiple Sclerosis, Chronic Progressive1
Muscle Spasticity1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.